Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea
More than 4.5 million Americans have congestive heart failure (CHF), close to 550,000 new cases are diagnosed each year, and one third of known patients with CHF are annually admitted to the hospital. Emergency department diagnosis of CHF is often based on history and physical examination findings a...
Gespeichert in:
| Veröffentlicht in: | Annals of emergency medicine 2003-04, Vol.41 (4), p.532-545 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 545 |
|---|---|
| container_issue | 4 |
| container_start_page | 532 |
| container_title | Annals of emergency medicine |
| container_volume | 41 |
| creator | Collins, Sean P. Ronan-Bentle, Sarah Storrow, Alan B. |
| description | More than 4.5 million Americans have congestive heart failure (CHF), close to 550,000 new cases are diagnosed each year, and one third of known patients with CHF are annually admitted to the hospital. Emergency department diagnosis of CHF is often based on history and physical examination findings along with results of ancillary tests, such as chest radiography and ECG. Although signs and symptoms of fluid overload, such as lower extremity edema and dyspnea, raise the suspicion of CHF, their lack of sensitivity makes them poor screening tools. The natriuretic peptides are promising markers of myocardial dysfunction and heart failure. Because of their relationship to myocardial pressure and stretching, natriuretic peptides have been investigated over the past 5 decades as both diagnostic and prognostic markers in acute coronary syndromes and CHF. This article discusses each of the natriuretic peptides and attempts to delineate their potential diagnostic and prognostic roles in the ED. [Ann Emerg Med. 2003;41:532-545.] |
| doi_str_mv | 10.1067/mem.2003.113 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73127681</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196064403000623</els_id><sourcerecordid>73127681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-363b5b3c7c4ba1d1f6f62730a904cc4b8957c652d5a2647e140689c491c7c38b3</originalsourceid><addsrcrecordid>eNptkD1v3DAMQIWiQXNNu3UutLRTfZEsWbLHIP1IgABZklmQJTpVYMuOKKe4fx8d7oosmQiSjwT5CPnC2ZYzpc8nmLY1Y2LLuXhHNpx1ulJasfdkw3inKqakPCUfER8ZY52s-QdyymvVtHUjN-TxZ7APccYcHLXR0yXN_9MVYVjHCIh0Hmi0OYU1wb6zwJKDB6QhUpggPUB0O-phsSlPEDNdbA4lIv0X8l_qd7hEsJ_IyWBHhM_HeEbuf_-6u7yqbm7_XF9e3FROKJkroUTf9MJpJ3vLPR_UoGotmO2YdKXWdo12qql9Y2slNXDJVNs52fEyItpenJHvh73ll6cVMJspoINxtBHmFY0WvNaq5QX8cQBdmhETDGZJYbJpZzgze7emuDV7t6a4LfjX4961n8C_wkeZBfh2BCw6Ow7JRhfwlZOqa2W759SBg2LhOUAy6IouBz4kcNn4Obx9wQstvZYP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73127681</pqid></control><display><type>article</type><title>Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Collins, Sean P. ; Ronan-Bentle, Sarah ; Storrow, Alan B.</creator><creatorcontrib>Collins, Sean P. ; Ronan-Bentle, Sarah ; Storrow, Alan B.</creatorcontrib><description>More than 4.5 million Americans have congestive heart failure (CHF), close to 550,000 new cases are diagnosed each year, and one third of known patients with CHF are annually admitted to the hospital. Emergency department diagnosis of CHF is often based on history and physical examination findings along with results of ancillary tests, such as chest radiography and ECG. Although signs and symptoms of fluid overload, such as lower extremity edema and dyspnea, raise the suspicion of CHF, their lack of sensitivity makes them poor screening tools. The natriuretic peptides are promising markers of myocardial dysfunction and heart failure. Because of their relationship to myocardial pressure and stretching, natriuretic peptides have been investigated over the past 5 decades as both diagnostic and prognostic markers in acute coronary syndromes and CHF. This article discusses each of the natriuretic peptides and attempts to delineate their potential diagnostic and prognostic roles in the ED. [Ann Emerg Med. 2003;41:532-545.]</description><identifier>ISSN: 0196-0644</identifier><identifier>EISSN: 1097-6760</identifier><identifier>DOI: 10.1067/mem.2003.113</identifier><identifier>PMID: 12658254</identifier><identifier>CODEN: AEMED3</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Acute Disease ; Atrial Natriuretic Factor - blood ; Atrial Natriuretic Factor - chemistry ; Biological and medical sciences ; Biomarkers - blood ; Biomarkers - chemistry ; Cardiology. Vascular system ; Diagnosis, Differential ; Discriminant Analysis ; Dyspnea - etiology ; Emergency Treatment - methods ; Emergency Treatment - standards ; Heart ; Heart Failure - blood ; Heart Failure - complications ; Heart Failure - diagnosis ; Heart Failure - epidemiology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Humans ; Mass Screening - methods ; Mass Screening - standards ; Medical sciences ; Natriuretic Peptide, Brain - blood ; Natriuretic Peptide, Brain - chemistry ; Natriuretic Peptide, C-Type - blood ; Natriuretic Peptide, C-Type - chemistry ; Nerve Tissue Proteins - blood ; Nerve Tissue Proteins - chemistry ; Patient Admission - statistics & numerical data ; Peptide Fragments - blood ; Peptide Fragments - chemistry ; Prognosis ; Protein Precursors - blood ; Protein Precursors - chemistry ; Reproducibility of Results ; Sensitivity and Specificity ; Stroke Volume ; United States - epidemiology</subject><ispartof>Annals of emergency medicine, 2003-04, Vol.41 (4), p.532-545</ispartof><rights>2003 American College of Emergency Physicians</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-363b5b3c7c4ba1d1f6f62730a904cc4b8957c652d5a2647e140689c491c7c38b3</citedby><cites>FETCH-LOGICAL-c364t-363b5b3c7c4ba1d1f6f62730a904cc4b8957c652d5a2647e140689c491c7c38b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0196064403000623$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14698484$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12658254$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Collins, Sean P.</creatorcontrib><creatorcontrib>Ronan-Bentle, Sarah</creatorcontrib><creatorcontrib>Storrow, Alan B.</creatorcontrib><title>Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea</title><title>Annals of emergency medicine</title><addtitle>Ann Emerg Med</addtitle><description>More than 4.5 million Americans have congestive heart failure (CHF), close to 550,000 new cases are diagnosed each year, and one third of known patients with CHF are annually admitted to the hospital. Emergency department diagnosis of CHF is often based on history and physical examination findings along with results of ancillary tests, such as chest radiography and ECG. Although signs and symptoms of fluid overload, such as lower extremity edema and dyspnea, raise the suspicion of CHF, their lack of sensitivity makes them poor screening tools. The natriuretic peptides are promising markers of myocardial dysfunction and heart failure. Because of their relationship to myocardial pressure and stretching, natriuretic peptides have been investigated over the past 5 decades as both diagnostic and prognostic markers in acute coronary syndromes and CHF. This article discusses each of the natriuretic peptides and attempts to delineate their potential diagnostic and prognostic roles in the ED. [Ann Emerg Med. 2003;41:532-545.]</description><subject>Acute Disease</subject><subject>Atrial Natriuretic Factor - blood</subject><subject>Atrial Natriuretic Factor - chemistry</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Biomarkers - chemistry</subject><subject>Cardiology. Vascular system</subject><subject>Diagnosis, Differential</subject><subject>Discriminant Analysis</subject><subject>Dyspnea - etiology</subject><subject>Emergency Treatment - methods</subject><subject>Emergency Treatment - standards</subject><subject>Heart</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - epidemiology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Humans</subject><subject>Mass Screening - methods</subject><subject>Mass Screening - standards</subject><subject>Medical sciences</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Natriuretic Peptide, Brain - chemistry</subject><subject>Natriuretic Peptide, C-Type - blood</subject><subject>Natriuretic Peptide, C-Type - chemistry</subject><subject>Nerve Tissue Proteins - blood</subject><subject>Nerve Tissue Proteins - chemistry</subject><subject>Patient Admission - statistics & numerical data</subject><subject>Peptide Fragments - blood</subject><subject>Peptide Fragments - chemistry</subject><subject>Prognosis</subject><subject>Protein Precursors - blood</subject><subject>Protein Precursors - chemistry</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Stroke Volume</subject><subject>United States - epidemiology</subject><issn>0196-0644</issn><issn>1097-6760</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkD1v3DAMQIWiQXNNu3UutLRTfZEsWbLHIP1IgABZklmQJTpVYMuOKKe4fx8d7oosmQiSjwT5CPnC2ZYzpc8nmLY1Y2LLuXhHNpx1ulJasfdkw3inKqakPCUfER8ZY52s-QdyymvVtHUjN-TxZ7APccYcHLXR0yXN_9MVYVjHCIh0Hmi0OYU1wb6zwJKDB6QhUpggPUB0O-phsSlPEDNdbA4lIv0X8l_qd7hEsJ_IyWBHhM_HeEbuf_-6u7yqbm7_XF9e3FROKJkroUTf9MJpJ3vLPR_UoGotmO2YdKXWdo12qql9Y2slNXDJVNs52fEyItpenJHvh73ll6cVMJspoINxtBHmFY0WvNaq5QX8cQBdmhETDGZJYbJpZzgze7emuDV7t6a4LfjX4961n8C_wkeZBfh2BCw6Ow7JRhfwlZOqa2W759SBg2LhOUAy6IouBz4kcNn4Obx9wQstvZYP</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>Collins, Sean P.</creator><creator>Ronan-Bentle, Sarah</creator><creator>Storrow, Alan B.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030401</creationdate><title>Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea</title><author>Collins, Sean P. ; Ronan-Bentle, Sarah ; Storrow, Alan B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-363b5b3c7c4ba1d1f6f62730a904cc4b8957c652d5a2647e140689c491c7c38b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acute Disease</topic><topic>Atrial Natriuretic Factor - blood</topic><topic>Atrial Natriuretic Factor - chemistry</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Biomarkers - chemistry</topic><topic>Cardiology. Vascular system</topic><topic>Diagnosis, Differential</topic><topic>Discriminant Analysis</topic><topic>Dyspnea - etiology</topic><topic>Emergency Treatment - methods</topic><topic>Emergency Treatment - standards</topic><topic>Heart</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - epidemiology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Humans</topic><topic>Mass Screening - methods</topic><topic>Mass Screening - standards</topic><topic>Medical sciences</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Natriuretic Peptide, Brain - chemistry</topic><topic>Natriuretic Peptide, C-Type - blood</topic><topic>Natriuretic Peptide, C-Type - chemistry</topic><topic>Nerve Tissue Proteins - blood</topic><topic>Nerve Tissue Proteins - chemistry</topic><topic>Patient Admission - statistics & numerical data</topic><topic>Peptide Fragments - blood</topic><topic>Peptide Fragments - chemistry</topic><topic>Prognosis</topic><topic>Protein Precursors - blood</topic><topic>Protein Precursors - chemistry</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Stroke Volume</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Collins, Sean P.</creatorcontrib><creatorcontrib>Ronan-Bentle, Sarah</creatorcontrib><creatorcontrib>Storrow, Alan B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Collins, Sean P.</au><au>Ronan-Bentle, Sarah</au><au>Storrow, Alan B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea</atitle><jtitle>Annals of emergency medicine</jtitle><addtitle>Ann Emerg Med</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>41</volume><issue>4</issue><spage>532</spage><epage>545</epage><pages>532-545</pages><issn>0196-0644</issn><eissn>1097-6760</eissn><coden>AEMED3</coden><abstract>More than 4.5 million Americans have congestive heart failure (CHF), close to 550,000 new cases are diagnosed each year, and one third of known patients with CHF are annually admitted to the hospital. Emergency department diagnosis of CHF is often based on history and physical examination findings along with results of ancillary tests, such as chest radiography and ECG. Although signs and symptoms of fluid overload, such as lower extremity edema and dyspnea, raise the suspicion of CHF, their lack of sensitivity makes them poor screening tools. The natriuretic peptides are promising markers of myocardial dysfunction and heart failure. Because of their relationship to myocardial pressure and stretching, natriuretic peptides have been investigated over the past 5 decades as both diagnostic and prognostic markers in acute coronary syndromes and CHF. This article discusses each of the natriuretic peptides and attempts to delineate their potential diagnostic and prognostic roles in the ED. [Ann Emerg Med. 2003;41:532-545.]</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>12658254</pmid><doi>10.1067/mem.2003.113</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0196-0644 |
| ispartof | Annals of emergency medicine, 2003-04, Vol.41 (4), p.532-545 |
| issn | 0196-0644 1097-6760 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73127681 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Acute Disease Atrial Natriuretic Factor - blood Atrial Natriuretic Factor - chemistry Biological and medical sciences Biomarkers - blood Biomarkers - chemistry Cardiology. Vascular system Diagnosis, Differential Discriminant Analysis Dyspnea - etiology Emergency Treatment - methods Emergency Treatment - standards Heart Heart Failure - blood Heart Failure - complications Heart Failure - diagnosis Heart Failure - epidemiology Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Mass Screening - methods Mass Screening - standards Medical sciences Natriuretic Peptide, Brain - blood Natriuretic Peptide, Brain - chemistry Natriuretic Peptide, C-Type - blood Natriuretic Peptide, C-Type - chemistry Nerve Tissue Proteins - blood Nerve Tissue Proteins - chemistry Patient Admission - statistics & numerical data Peptide Fragments - blood Peptide Fragments - chemistry Prognosis Protein Precursors - blood Protein Precursors - chemistry Reproducibility of Results Sensitivity and Specificity Stroke Volume United States - epidemiology |
| title | Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A24%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20and%20prognostic%20usefulness%20of%20natriuretic%20peptides%20in%20emergency%20department%20patients%20with%20dyspnea&rft.jtitle=Annals%20of%20emergency%20medicine&rft.au=Collins,%20Sean%20P.&rft.date=2003-04-01&rft.volume=41&rft.issue=4&rft.spage=532&rft.epage=545&rft.pages=532-545&rft.issn=0196-0644&rft.eissn=1097-6760&rft.coden=AEMED3&rft_id=info:doi/10.1067/mem.2003.113&rft_dat=%3Cproquest_cross%3E73127681%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73127681&rft_id=info:pmid/12658254&rft_els_id=S0196064403000623&rfr_iscdi=true |